Showing results (61-70 of 185) with videos related to

Sort By:
Pageof 19
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 22, 2020
Prevalence and characteristics of portopulmonary hypertension in cirrhotic patients who underwent both hepatic vein and pulmonary artery catheterizationMasanori Atsukawa, Akihito Tsubota, Masaru Hatano, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 3, 2025
Evaluating two rechallenge strategies of immune checkpoint inhibitors: Durvalumab plus tremelimumab in advanced hepatocellular carcinomaTakuya Yonemoto, Sadahisa Ogasawara, Naoya Kanogawa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 29, 2018
Efficacy and safety of ombitasvir/paritaprevir/ritonavir and ribavirin for chronic hepatitis patients infected with genotype 2a in JapanMasanori Atsukawa, Akihito Tsubota, Hidenori Toyoda, et al.
Journal of Gastroenterology and Hepatology|July 28, 2023
Apolipoprotein A2 isoforms associated with exocrine pancreatic insufficiency in early chronic pancreatitisSeiji Futagami, Shuhei Agawa, Ken Nakamura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 7, 2026
Prognostic Value of an Early Response to Tolvaptan and Its Clinical Implications in Patients With Cirrhosis and Hepatic Edema: A Nationwide Multicenter Cohort StudyKaori Koyano, Taeang Arai, Hidenori Toyoda, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 30, 2024
Kinetics of the hepatitis B core-related antigen and treatment responses in chronic hepatitis B patients treated with tenofovir alafenamideNorio Itokawa, Masanori Atsukawa, Akihito Tsubota, et al.
Liver Cancer|March 27, 2025
Assessment of Macrovascular Invasion in Advanced Hepatocellular Carcinoma: Clinical Implications and Treatment Outcomes with Systemic TherapyMasanori Inoue, Sadahisa Ogasawara, Kazufumi Kobayashi, et al.
Hepatology International|July 4, 2024
Clinical significance of circulating biomarkers of immune-checkpoint molecules with atezolizumab plus bevacizumab therapy in unresectable hepatocellular carcinomaMakoto Chuma, Haruki Uojima, Hidenori Toyoda, et al.
Gastro Hep Advances|August 12, 2024
The Impact of Cirrhosis and History of Hepatocellular Carcinoma on All-Cause Mortality After Eradication of Hepatitis C Virus in Patients With Chronic Hepatitis CHidenori Toyoda, Masanori Atsukawa, Haruki Uojima, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 21, 2026
Prospective Study of Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma Based on Hepatobiliary Phase of Gd-EOB-DTPA-MRITomoko Aoki, Masatoshi Kudo, Kazuomi Ueshima, et al.
Pageof 19